Helix TCS creates proprietary software that helps cannabis businesses manage inventory and supply costs. They also provide ancillary services to the cannabis industry including security operations, transportation, armed and unarmed guarding, training, and other special services.
Whereas, BioTrackTHC is a technology driven company that develops software that provides government regulators the ability to track and capture data from seed-to-sale. This allows cannabis businesses can stay compliant with State and Federal laws. BioTrackTHC has 9 government contracts in place utilize their technology, as well as, currently provides inventory management and POS solutions to over 2,000 cannabis operations around the world.
Its is clear that the result of this merger will be creating one of the largest ancillary driven cannabis public companies. Though the two companies will still run independently of each other, the merged entity will be able to meet any and every need a cannabis business many need.
Zachary Venegas, CEO of Helix TCS, Inc. added: “The synergies between Cannabase and BioTrack are significant, and we will use them as a starting point for an industry defining platform. The combined firm’s increased scope, linked with our focus on execution, will continue to set the standard for M&A in the industry”.
You may be interested
MedMen Begins Construction of Cannabis Cultivation and Manufacturing Facility in CaliforniaSam Rosenberg - May 24, 2018
Med Men Enterprises has begun construction on a large scale cultivation and manufacturing facility in Desert Hot Springs, California. The new facility is expected to become operational…
Canopy Growth Corp. to Begin Trading on New York Stock Exchange TodaySam Rosenberg - May 24, 2018
Canopy Growth Corporation (TSX: WEED) announced this morning that the company is expected to begin trading on the New York Stock Exchange (NYSE) this morning under the ticker…
Colorado Passes Bill to Allow Public Companies to Invest into Cannabis BusinessesSam Rosenberg - May 23, 2018
Colorado has just passed a House Bill 18-1011 which will allow publicly trade companies in the U.S. to invest and hold medicinal or recreational cannabis cultivation, processing,…